|
Melsheimer P, Kaul S, Dobeck S, Bastert G. 2003. Immunocytochemical detection of HPV high risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol 47: 124-128.
Griesser H, Sander H, Hilfrich R, Moser B, Schenck U. 2004.Correlation of immunochemical detection of HPV L1 capsid protein in Pap smears with regression of high risk HPV positive mild/moderate dysplasia. Anal Quant Cytol Histl 26: 241-245.
Griesser H, Sander H, Hilfrich R. 2006. HPV L1 capsid protein detection as prognostic marker for hr HPV associated early dysplastic lesions. Pathologica 98: 368.
Griesser H, Sander H, Walczak C, Hilfrich R. 2007. Immunochemical detection of HPV L1 capsid protein : prognostic marker for early sqamous lesions of the cervix. Acta cytologica 52: 268.
Regauer S. 2007. Standard histological and immunohistological work up of cervical biopsies and endocervical currettings. Gyn 12: 37-38.
Rauber D, Mehlhorn G, Fasching P.A, Beckmann M.W, Ackermann S. 2008. Prognostic significance of the detection of the human papillomavirus L1 protein in smears of mild to moderate cervical intraepithelial lesions. Eur J Obstet Gynecol Reprod Biol 140, 2: 258- 262.
Hilfrich R, Hariri J. 2008. Prognostic relevance of HPV L1 capsid protein detection within mild to moderate dysplastic lesions of the cervix uteri in combination with a second biomarker p16. Anal Quant Cytol Histl 30:78-82.
Negri G, Bellisano G, Zannoni G.F et al. 2008. p16 and HPV immunohistochemistry is helpful for estimating the behaviour of low grade dysplastic lesions of the cervix uteri. Am J Surg Pathol 32(11): 1715-1720.
Griesser H, Sander H, Hilfrich R. 2009. HPV L1 capsid protein detection as prognostic marker for HR HPV associated early dysplastic lesions. Am J Clin Pathol, Submitted.
|
copyright cytoimmun 2007